Know. Connect. Thrive.

Our longstanding commitment to research has helped drive progress in understanding, diagnosing, and treating Marfan syndrome, Loeys-Dietz syndrome (LDS), Vascular Ehlers-Danlos syndrome (VEDS), and related conditions. We collaborate with leading scientists and healthcare professionals to advance discoveries that improve diagnosis, treatment, and care.

Since 1986, the Marfan Foundation has invested more than $24 million in research through grants and other strategic initiatives. Our research grant program has helped grow the community of researchers studying these conditions and has contributed to discoveries, including the identification of additional genetic aortic and vascular conditions related to Marfan syndrome.

We also advocate for increased government investment in research and bring researchers, healthcare professionals, government agencies, and other health organizations together through conferences, symposia, and other opportunities to share knowledge and accelerate progress.

Because advances in one area can benefit the broader genetic aortic and vascular condition community, we remain committed to supporting research that improves health outcomes and quality of life for individuals and families.

2025 Studies

During the 2025 grant cycle, we received 63 proposals and awarded seven research grants to scientists ranging from seasoned investigators to emerging researchers. As a result of our efforts in 2025, grants will help researchers investigate some of the following areas of study:

  • Understanding macrophage inflammation in Marfan syndrome
  • Evaluating a targeted nanotherapy designed to reinforce a weakened aorta
  • Exploring the role of senescent cells in aneurysm formation

In addition to the newly awarded research grants, the Foundation provided funding for additional researchers who were awarded multi-year grants in the past two years. 

To view all funded research grant recipients since 2014, click here.